Michelle Brewstein

Michelle Brewstein has a diverse work experience spanning over two decades. Michelle started their career as an intern at McGrail Merkel Quinn & Associates in 2000. From 2001 to 2008, they worked at Deloitte & Touche, progressing to the role of Audit Manager.

In 2008, they became an Accounting Manager at DSM Biomedical (formerly Kensey Nash Corporation), which was subsequently acquired by Royal DSM in 2012. During their time at Royal DSM - DSM Biomedical from 2013 to 2015, Michelle served as the Accounting & Internal Controls Manager.

In 2015, they joined Signant Health as a Controller, which specializes in providing digital solutions for clinical trials. Michelle held this position until 2023, prior to joining their current company, IntegriChain, in 2024. At IntegriChain, they serve as the Executive Director of Financial Reporting.

Michelle's diverse background includes expertise in financial reporting, accounting, audit management, and internal controls.

Michelle Brewstein graduated from the University of Scranton in 2001 with a Bachelor's degree in Accounting. Michelle also holds additional certification as a Certified Public Accountant in Pennsylvania.